Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kherani JF"'
Autor:
Shah NN; Medical College of Wisconsin, Milwaukee, WI. nishah@mcw.edu., Wang M; MD Anderson Cancer Center, Houston, TX., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY., Patel K; Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Wierda WG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Ujjani CS; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford., Zinzani PL; Institute of Hematology 'Seragnoli' University of Bologna, Bologna., Alencar AJ; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Ghia P; Universita Vita-Salute San Raffaele, Milano, Italy; IRCCS Ospedale San Raffaele, Milano., Lamanna N; New York-Presbyterian Columbia University Medical Center, New York, NY., Hoffmann MS; Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL., Flinn I; Sarah Cannon Research Institute, Nashville, TN., Gerson JN; Lymphoma Program, Abramson Cancer Center, Philadelphia, PA., Ma S; Robert H. Lurie Comprehensive Cancer Center, Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL., Coombs CC; University of California Irvine, Irvine, CA., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth., Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Fakhri B; Division of Hematology at Stanford University School of Medicine, Stanford, CA., Kim WS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul., Barve MA; Mary Crowley Cancer Research Center, Dallas, TX., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Munir T; Department of Haematology, St. James's University Hospital, Leeds., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, NY., Tsai DE; Loxo@Lilly, Indianapolis, IN., Bao K; Loxo@Lilly, Indianapolis, IN., Cangemi NA; Loxo@Lilly, Indianapolis, IN., Kherani JF; Loxo@Lilly, Indianapolis, IN., Walgren RA; Loxo@Lilly, Indianapolis, IN., Han H; Loxo@Lilly, Indianapolis, IN., Ruppert AS; Eli Lilly and Company, Indianapolis, IN., Brown JR; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 03. Date of Electronic Publication: 2024 Oct 03.
Autor:
Wickremsinhe E; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Fantana A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Berthier E; Tasso Inc., Seattle, WA, USA., Quist BA; Tasso Inc., Seattle, WA, USA., Lopez de Castilla D; Evergreen Health Medical Center, Kirkland, WA 98034, USA., Fix C; Q2 Solutions, Valencia, CA, USA., Chan K; Q2 Solutions, Valencia, CA, USA., Shi J; Walker Bioscience, Carlsbad, CA, USA., Walker MG; Walker Bioscience, Carlsbad, CA, USA., Kherani JF; Loxo Oncology, Stamford, CT 06901, USA., Knoderer H; Lilly Oncology, Eli Lilly and Company, Indianapolis, IN, USA., Regev A; Global Patient Safety, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The journal of applied laboratory medicine [J Appl Lab Med] 2023 May 04; Vol. 8 (3), pp. 535-550.
Autor:
McCoach CE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Genentech, Inc., South San Francisco, California. Electronic address: caroline.mccoach@ucsf.edu., Rolfo C; Greenebaum Comprehensive Cancer Center, Experimental Therapeutics Program, School of Medicine, University of Maryland, Baltimore, Maryland; Present Address: Center for Thoracic Oncology at Tisch Cancer Institute, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York., Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lacouture M; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Zhu VW; Department of Medicine, Division of Hematology and Oncology, University of California Irvine, Orange, California., Tan DSW; National Cancer Centre Singapore, Duke-National University of Singapore Medical School, Singapore., Farajian S; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Potter LA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Davis School of Medicine, University of California, Sacramento, Sacramento, California., Kherani JF; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Soldatenkova V; Eli Lilly and Company, Indianapolis, Indiana., Olek EA; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Muehlenbein CE; Eli Lilly and Company, Indianapolis, Indiana., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jun; Vol. 17 (6), pp. 768-778. Date of Electronic Publication: 2022 Feb 17.
Autor:
Subbiah V; The University of Texas, MD Anderson Cancer Center, Houston, Texas. vsubbiah@mdanderson.org., Gainor JF; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Oxnard GR; Dana-Farber Cancer Institute, Boston, Massachusetts., Tan DSW; National Cancer Centre Singapore, Duke-NUS Medical School, Singapore., Owen DH; The Ohio State University, Columbus, Ohio., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Loong HH; The Chinese University of Hong Kong, Hong Kong, PR China., McCoach CE; University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Weiss J; University of North Carolina, Chapel Hill, North Carolina., Kim YJ; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Republic of Korea., Bazhenova L; University of California, San Diego Moores Cancer Center, San Diego, California., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Daga H; Osaka City General Hospital, Osaka, Japan., Besse B; Institut Gustav Roussy, Villejuif, France; Paris-Saclay University, Orsay, France., Gautschi O; University of Berne and Cantonal Hospital of Lucerne, Lucerne, Switzerland., Rolfo C; Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.; Center for Thoracic Oncology, Tisch Cancer Institute Mount Sinai Medical System- Icahn School of Medicine, Mount Sinai, New York, New York., Zhu EY; Loxo Oncology, a subsidiary of Eli Lilly and Company, Indianapolis, Indiana., Kherani JF; Loxo Oncology, a subsidiary of Eli Lilly and Company, Indianapolis, Indiana., Huang X; Loxo Oncology, a subsidiary of Eli Lilly and Company, Indianapolis, Indiana., Kang S; Eli Lilly and Company, Indianapolis, Indiana., Drilon A; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Aug 01; Vol. 27 (15), pp. 4160-4167. Date of Electronic Publication: 2021 Jun 04.
Autor:
Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Johnson ML; Department of Medicine, Sarah Cannon Cancer Center, Nashville, Tennessee., Clifford SE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Somwar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Kherani JF; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Son J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bertram AA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Davare MA; Oregon Health and Science University, Portland, Oregon., Gladstone E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Ivanova EV; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Henry DN; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Kelley EM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lin M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Milan MSD; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nair BC; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Olek EA; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Scanlon JE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Vojnic M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Ebata K; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Hechtman JF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Taylor BS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rothenberg SM; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. drilona@mskcc.org.; Weill Cornell Medical College, New York, New York., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 34-42. Date of Electronic Publication: 2020 Oct 20.
Autor:
Minkowitz S; Department of Radiology New York-Presbyterian Hospital-Weill Cornell Medicine Brooklyn NY., Leeman K; Department of Radiology New York-Presbyterian Hospital-Weill Cornell Medicine Brooklyn NY., Giambrone AE; Department of Biostatistics and Epidemiology Weill Cornell Medicine Brooklyn NY., Kherani JF; Department of Emergency Medicine New York-Presbyterian Hospital-Weill Cornell Medicine Brooklyn NY., Belfi LM; Department of Radiology New York-Presbyterian Hospital-Weill Cornell Medicine Brooklyn NY., Bartolotta RJ; Department of Radiology New York-Presbyterian Hospital-Weill Cornell Medicine Brooklyn NY.
Publikováno v:
AEM education and training [AEM Educ Train] 2017 Jan 19; Vol. 1 (1), pp. 43-47. Date of Electronic Publication: 2017 Jan 19 (Print Publication: 2017).
Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations.
Autor:
Povsic TJ; Duke University Medical Center, Durham, NC 27710, USA. povsi001@mc.duke.edu, Zavodni KL, Vainorius E, Kherani JF, Goldschmidt-Clermont PJ, Peterson ED
Publikováno v:
American heart journal [Am Heart J] 2009 Feb; Vol. 157 (2), pp. 335-44. Date of Electronic Publication: 2008 Dec 09.